Digital health

Artificial intelligence: It’s about TIME

In the second of our two-part look at the Longevity implications of TIME's 2019 Best Inventions list (following Agetech), we take a look at the...

Meet the Start-up: Sonde Health’s voice biomarker

Vocal biomarker monitors changes in the voice to detect mental and physical health conditions. Could our voice prove to be the “ultimate biomarker” when it...

Apple shores up wearables dominance

Apple is continuing its drive towards dominance in the health wearables market by hiring another leading cardiologist. According to a report from CNBC, Apple has...

Bayer backs 11 digital health and AI startups

Pharma giant Bayer is pursuing ambitious collaborations with Longevity-based companies, but Roundup pressure continues to mount. Bayer AG, the multinational pharmaceutical and life sciences company,...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.